The Informed Genetics Annotated Patient Registry (iGAP)

This study, called the iGAP Registry, is looking at how genetic and other biomarker tests are used in different healthcare settings. It aims to understand how these tests, like Germline Genetic and Genomic testing, help doctors make decisions about patient care and personalized treatments. The study will follow people for 10 years to see how these tests impact health outcomes over time. This information will help create better guidelines for using these tests and improve patient management. You might be able to join if you are 18 or older, have had a Germline, Genomic, or other Biomarker test, and for Germline Genetic tests, have a cancer diagnosis or a specific genetic result. The current recruitment status is unclear.

Study design: This is an observational study, meaning researchers will collect information without giving any specific interventions. It plans to include up to 10,000 participants.
What's involved: Not specified in the trial record.
Compensation: Not stated in the trial record.
Follow-up: The study aims to understand test utilization over 10 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

The Informed Genetics Annotated Patient Registry

Enrolling by Invitation

Not specifiedAges 18+Observational

Medneon

~10,000 participants

Updated 2022-04-05 on ClinicalTrials.gov

At a glance

Recruiting sites

0 of 5 listed sites are recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

To understand the utilization of Germline Genetic, Genomic, and Biomarker Testing in various clinical settings.

Measured over 10 years

Conditions

Predisposition, Genetic

Where it's being run

5 sites across 5 states

California1

Illinois1

Michigan1

Tennessee1

Texas1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

Men and women 18 years or older;

Is or was a patient of a Participating Practice and was previously tested with Germline, Genomic, or other Biomarker Tests; and

For Germline Genetic Test patients, have a diagnosis of cancer or pathogenic or likely pathogenic (P/LP) result.

Men and women aged 18 years or older;

Presents consecutively to a Participating Practice and who has previously been screened and tested (i.e., is a new patient scheduled for a visit at a Participating Practice or is an existing patient who returns to a Participating Practice);

Receives or has received Germline, Genomic, or other Biomarker Testing, either through a prior healthcare provider or a Participating Practice; and

Consents to be a part of the Registry.

What this trial measures

To understand the utilization of Germline Genetic, Genomic, and Biomarker Testing in various clinical settings.10 years
To understand the utilization of Germline Genetic, Genomic, and Biomarker Testing in various clinical settings. The registry will gather information on patient demographics and personal and family history, as well as test results of Germline Genetic, Genomic, and Biomarker tests.

Trialytics